Medical Treatment in Cushing’s Syndrome: Dopamine Agonists and Cabergoline

Publisher： Karger

E-ISSN： 1423-0194|92|1|116-119

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.92, Iss.1, 2010-09, pp. : 116-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medical Treatment of Cushing’s Syndrome: Adrenal-Blocking Drugs and Ketaconazole

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 111-115

Karger

Access to resources Recommend Favorite

Medical Treatment of Cushing’s Syndrome: Glucocorticoid Receptor Antagonists and Mifepristone

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 125-130

Karger

Access to resources Recommend Favorite

Hypertension in Cushing’s Syndrome: From Pathogenesis to Treatment

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 44-49

Karger

Access to resources Recommend Favorite

Coagulopathy in Cushing’s Syndrome

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 55-59

Karger

Access to resources Recommend Favorite

Genetics of Cushing’s Syndrome

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 6-10

Karger

Access to resources Recommend Favorite